$OPCH
Option Care Health, Inc.

2014 Q1 Form 10-Q Financial Statement

#000101473914000006 Filed on May 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $239.3M $181.1M
YoY Change 32.12% 16.38%
Cost Of Revenue $174.2M $125.1M
YoY Change 39.19% 22.56%
Gross Profit $62.14M $55.99M
YoY Change 10.99% 4.61%
Gross Profit Margin 25.97% 30.91%
Selling, General & Admin $65.80M $50.10M
YoY Change 31.34% 4.38%
% of Gross Profit 105.89% 89.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.836M $2.418M
YoY Change 58.64% 25.22%
% of Gross Profit 6.17% 4.32%
Operating Expenses $65.30M $52.20M
YoY Change 25.1% 6.75%
Operating Profit -$11.27M -$2.187M
YoY Change 415.13% -154.08%
Interest Expense $10.50M $6.478M
YoY Change 62.07% -1.39%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$23.61M -$8.538M
YoY Change 176.48% 238.14%
Income Tax $3.491M -$224.0K
% Of Pretax Income
Net Earnings -$25.31M -$8.128M
YoY Change 211.44% 200.7%
Net Earnings / Revenue -10.58% -4.49%
Basic Earnings Per Share -$0.37 -$0.14
Diluted Earnings Per Share -$1.480M -$0.14
COMMON SHARES
Basic Shares Outstanding 68.17M shares 57.05M shares
Diluted Shares Outstanding 57.05M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.300M $0.00
YoY Change
Cash & Equivalents $9.253M $0.00
Short-Term Investments
Other Short-Term Assets $12.30M $9.100M
YoY Change 35.16% -76.42%
Inventory $34.75M $22.82M
Prepaid Expenses
Receivables $195.1M $158.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $251.3M $190.0M
YoY Change 32.27% -35.49%
LONG-TERM ASSETS
Property, Plant & Equipment $39.95M $27.77M
YoY Change 43.89% 5.86%
Goodwill $571.8M $414.2M
YoY Change 38.05% 32.6%
Intangibles $15.12M $19.36M
YoY Change -21.91% 10.99%
Long-Term Investments $10.40M
YoY Change
Other Assets $3.576M $1.385M
YoY Change 158.19% -2.46%
Total Long-Term Assets $648.7M $475.7M
YoY Change 36.38% 25.36%
TOTAL ASSETS
Total Short-Term Assets $251.3M $190.0M
Total Long-Term Assets $648.7M $475.7M
Total Assets $900.1M $665.7M
YoY Change 35.2% -1.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $68.29M $32.11M
YoY Change 112.68% -62.11%
Accrued Expenses $45.00M $49.20M
YoY Change -8.54% 22.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $28.00M
YoY Change -98.57% -56.29%
Total Short-Term Liabilities $127.6M $133.2M
YoY Change -4.2% -39.02%
LONG-TERM LIABILITIES
Long-Term Debt $418.2M $225.4M
YoY Change 85.54% -0.84%
Other Long-Term Liabilities $8.940M $8.971M
YoY Change -0.35% 143.71%
Total Long-Term Liabilities $8.940M $8.971M
YoY Change -0.35% -96.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $127.6M $133.2M
Total Long-Term Liabilities $8.940M $8.971M
Total Liabilities $567.4M $378.2M
YoY Change 50.01% -17.66%
SHAREHOLDERS EQUITY
Retained Earnings -$180.1M -$93.21M
YoY Change 93.16% -38.87%
Common Stock $523.0M $391.0M
YoY Change 33.77% 3.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.31M $10.31M
YoY Change 0.0% -1.43%
Treasury Stock Shares 2.583M shares 2.583M shares
Shareholders Equity $332.7M $287.5M
YoY Change
Total Liabilities & Shareholders Equity $900.1M $665.7M
YoY Change 35.2% -1.23%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$25.31M -$8.128M
YoY Change 211.44% 200.7%
Depreciation, Depletion And Amortization $3.836M $2.418M
YoY Change 58.64% 25.22%
Cash From Operating Activities -$25.99M -$12.85M
YoY Change 102.26% -608.83%
INVESTING ACTIVITIES
Capital Expenditures -$3.100M -$3.600M
YoY Change -13.89% 140.0%
Acquisitions $0.00 $72.33M
YoY Change -100.0%
Other Investing Activities $56.60M -$73.30M
YoY Change -177.22% 36550.0%
Cash From Investing Activities $53.56M -$76.88M
YoY Change -169.66% 4315.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$19.32M $27.63M
YoY Change -169.92% -3623.85%
NET CHANGE
Cash From Operating Activities -$25.99M -$12.85M
Cash From Investing Activities $53.56M -$76.88M
Cash From Financing Activities -$19.32M $27.63M
Net Change In Cash $8.252M -$62.10M
YoY Change -113.29%
FREE CASH FLOW
Cash From Operating Activities -$25.99M -$12.85M
Capital Expenditures -$3.100M -$3.600M
Free Cash Flow -$22.89M -$9.248M
YoY Change 147.47% -329.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
68288000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
63575000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42016000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45000000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
519625000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
523011000 USD
CY2014Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1703000 USD
CY2013Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2082000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17836000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23660000 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
66000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
356000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1877000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
356000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1943000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2082000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1703000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6500000.0 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3800000.0 shares
CY2013Q4 us-gaap Assets
Assets
936858000 USD
CY2014Q1 us-gaap Assets
Assets
900076000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
236955000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
251349000 USD
CY2014Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
15316000 USD
CY2014Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Noncurrent
AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Noncurrent
AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
49643000 USD
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
576000 USD
CY2014Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
846000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
903000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
355000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1001000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9253000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62101000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
43000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
102000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
398000 USD
CY2014Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2014Q1 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
500000 USD
CY2013Q1 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
400000 USD
CY2014Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
14918000 USD
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
13746000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8252000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-62101000 USD
CY2014Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
56616000 USD
CY2013Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-32000 USD
CY2014Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1505000 USD
CY2013Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
1291000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70784560 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70711439 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68128919 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68202040 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
7000 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2014Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3530000 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
8815000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
174501000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
125148000 USD
CY2013Q1 us-gaap Cost Of Services
CostOfServices
19615000 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
22737000 USD
CY2013Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-702000 USD
CY2014Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
783000 USD
CY2013Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-677000 USD
CY2014Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
783000 USD
CY2013Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
25000 USD
CY2014Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2396000 USD
CY2013Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
396000 USD
CY2014Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1200000 USD
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
17184000 USD
CY2014Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
18247000 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
453000 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2708000 USD
CY2014Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
312000 USD
CY2013Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
57000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
8954000 USD
CY2014Q1 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
12677000 USD
CY2014Q1 us-gaap Deposit Assets
DepositAssets
700000 USD
CY2013Q2 us-gaap Deposit Assets
DepositAssets
1100000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
2418000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
3836000 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4860000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1799000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3078000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5318000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15121000 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4291000 USD
CY2014Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4424000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13000 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014Q1 us-gaap Goodwill
Goodwill
571830000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
571337000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
65142000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
55981000 USD
CY2014Q1 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
151764000 USD
CY2013Q1 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
105533000 USD
CY2014Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
215900000 USD
CY2013Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
150024000 USD
CY2013Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
31105000 USD
CY2014Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
23743000 USD
CY2013Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
181129000 USD
CY2014Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
239643000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-25422000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8441000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8665000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21931000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.15
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
313000 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
108000 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-224000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3491000 USD
CY2014Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10601000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3071000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3033000 USD
CY2014Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7670000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
385000 USD
CY2014Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
51000 USD
CY2013Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-135000 USD
CY2014Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
509000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-512000 USD
CY2014Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
0 USD
CY2013Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-6000 USD
CY2014Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-314000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4644000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2777000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2708000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-457000 USD
CY2014Q1 us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
5365000 USD
CY2013Q1 us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
187000 USD
CY2013Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5772000 USD
CY2014Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
134000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13199000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
413000 USD
CY2013Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-10173000 USD
CY2014Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
634000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2501000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1475000 USD
CY2014Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
22903000 USD
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
17554000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16824000 USD
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15121000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
6478000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
10499000 USD
CY2013Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0 USD
CY2014Q1 us-gaap Interest Expense Other
InterestExpenseOther
85000 USD
CY2013Q1 us-gaap Interest Expense Other
InterestExpenseOther
46000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
900076000 USD
CY2013Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6478000 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10499000 USD
CY2013Q1 us-gaap Interest Paid Net
InterestPaidNet
322000 USD
CY2014Q1 us-gaap Interest Paid Net
InterestPaidNet
8476000 USD
CY2014Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2307000 USD
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2173000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
34341000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
34754000 USD
CY2014Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2000000 USD
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12082000 USD
CY2014Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
12379000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
582275000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
567420000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
936858000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
127565000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
174306000 USD
CY2013Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
6576000 USD
CY2014Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2013Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
6153000 USD
CY2014Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
418238000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
375322000 USD
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
431000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
60257000 USD
CY2014Q1 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
26500000 USD
CY2014Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
3500000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19318000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27627000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76880000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
53556000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-76848000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3060000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12848000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14139000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24481000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-8128000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-25314000 USD
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2013Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
900000 USD
CY2014Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25986000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2187000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11432000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
33113000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
6807000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3594000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
5209000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
6215000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7798000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3490000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3733000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3576000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17540000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8940000 USD
CY2014Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
59384000 USD
CY2013Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
47005000 USD
CY2013Q2 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-8500000 USD
CY2013Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
3623000 USD
CY2014Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
3060000 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1211000 USD
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
72325000 USD
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12252000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14110000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
193810000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
427000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
642000 USD
CY2013Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
214145000 USD
CY2014Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
64600000 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-172243000 USD
CY2013Q1 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83198000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84953000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41182000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39953000 USD
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6605000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3180000 USD
CY2014Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
195090000 USD
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
172187000 USD
CY2014Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
104603000 USD
CY2013Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
187092000 USD
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
68000 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
98000 USD
CY2013Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
200000 USD
CY2014Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
1100000 USD
CY2014Q1 us-gaap Restructuring Charges
RestructuringCharges
4592000 USD
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
1278000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-154738000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180052000 USD
CY2014Q1 us-gaap Revenues
Revenues
239643000 USD
CY2013Q1 us-gaap Revenues
Revenues
181129000 USD
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68171000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57047000 shares
CY2013Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
34352000 USD
CY2014Q1 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
42663000 USD
CY2013Q1 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
4623000 USD
CY2014Q1 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
6499000 USD
CY2014Q1 bios Adjusted Ebitda
AdjustedEbitda
16528000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1973000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2886000 USD
CY2014Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1800000 USD
CY2013Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1400000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
332656000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
354583000 USD
CY2014Q1 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
7913000 USD
CY2013Q4 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
2547000 USD
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
CY2013Q1 bios Adjusted Ebitda
AdjustedEbitda
18104000 USD
CY2014Q1 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
5963000 USD
CY2013Q4 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
4826000 USD
CY2014Q1 bios Capital Lease Obligations Incurred To Acquire Property And Equipment
CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment
0 USD
CY2013Q1 bios Capital Lease Obligations Incurred To Acquire Property And Equipment
CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment
0 USD
CY2013Q4 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
19961000 USD
CY2014Q1 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
22777000 USD
CY2012Q4 bios Disposal Group Including Discontinued Operation Proceeds
DisposalGroupIncludingDiscontinuedOperationProceeds
173800000 USD
CY2014Q1 bios Duefrom Saleof Affiliate Equity Investment Noncurrent
DuefromSaleofAffiliateEquityInvestmentNoncurrent
2100000 USD
CY2014Q1 bios Employee Stock Ownership Plan Shares Registered
EmployeeStockOwnershipPlanSharesRegistered
750000 shares
CY2014Q1 bios Finite Lived Intangible Assets Amortization Expense Year Fiveand Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandThereafter
66000 USD
CY2014Q1 bios Future Minimum Leases Due Thereafter
FutureMinimumLeasesDueThereafter
3490000 USD
CY2014Q1 bios Future Minimum Payments Due
FutureMinimumPaymentsDue
34016000 USD
CY2014Q1 bios Future Minimum Payments Due Current
FutureMinimumPaymentsDueCurrent
7162000 USD
CY2014Q1 bios Future Minimum Payments Due In Five Years
FutureMinimumPaymentsDueInFiveYears
3599000 USD
CY2014Q1 bios Future Minimum Payments Due In Four Years
FutureMinimumPaymentsDueInFourYears
5252000 USD
CY2014Q1 bios Future Minimum Payments Due In Three Years
FutureMinimumPaymentsDueInThreeYears
6317000 USD
CY2014Q1 bios Future Minimum Payments Due In Two Years
FutureMinimumPaymentsDueInTwoYears
8196000 USD
CY2014Q1 bios Gain Losson Changein Fair Valueof Contingent Consideration
GainLossonChangeinFairValueofContingentConsideration
2209000 USD
CY2013Q1 bios Gain Losson Changein Fair Valueof Contingent Consideration
GainLossonChangeinFairValueofContingentConsideration
0 USD
CY2014Q1 bios Increase Decreasein Amountsduetoplansponsor
IncreaseDecreaseinAmountsduetoplansponsor
1138000 USD
CY2013Q1 bios Increase Decreasein Amountsduetoplansponsor
IncreaseDecreaseinAmountsduetoplansponsor
-4152000 USD
CY2014Q1 bios Increase Decreasein Fair Valueof Contingent Consideration
IncreaseDecreaseinFairValueofContingentConsideration
2209000 USD
CY2013Q1 bios Increase Decreasein Fair Valueof Contingent Consideration
IncreaseDecreaseinFairValueofContingentConsideration
0 USD
CY2013Q4 bios Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
16526000 USD
CY2014Q1 bios Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
18229000 USD
CY2014Q1 bios Intangible Assets Gross
IntangibleAssetsGross
33350000 USD
CY2013Q4 bios Intangible Assets Gross
IntangibleAssetsGross
33350000 USD
CY2014Q1 bios Interestratelegalsettlement
Interestratelegalsettlement
0.0325
CY2013Q4 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
435579000 USD
CY2014Q1 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
418669000 USD
CY2014Q1 bios Medical Equipment Gross
MedicalEquipmentGross
24793000 USD
CY2013Q4 bios Medical Equipment Gross
MedicalEquipmentGross
22247000 USD
CY2014Q1 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Noncash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveNoncash
152000 USD
CY2014Q1 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Settled In Cash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveSettledInCash
4427000 USD
CY2013Q4 bios Onetimecostsrelatedtopharmacyservicesassetsalereserve
Onetimecostsrelatedtopharmacyservicesassetsalereserve
16287000 USD
CY2014Q1 bios Onetimecostsrelatedtopharmacyservicesassetsalereserve
Onetimecostsrelatedtopharmacyservicesassetsalereserve
12697000 USD
CY2013Q1 bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
1279000 USD
CY2014Q1 bios Restructuring Charges Other Expensesand Investments
RestructuringChargesOtherExpensesandInvestments
5560000 USD
CY2014Q1 bios Restructuringcoststransactioncostsandotheronetimechargesasaresultofthetransaction
Restructuringcoststransactioncostsandotheronetimechargesasaresultofthetransaction
989000 USD
CY2013Q2 bios Saleof Affiliate Equity Investment Period After Close Expectedto Receive Additional Servicesor Cash
SaleofAffiliateEquityInvestmentPeriodAfterCloseExpectedtoReceiveAdditionalServicesorCash
P2Y
CY2014Q1 bios Stock Appreciation Right Benefit Expense
StockAppreciationRightBenefitExpense
-100000 USD
CY2013Q1 bios Stock Appreciation Right Benefit Expense
StockAppreciationRightBenefitExpense
400000 USD
CY2013Q1 bios Transitional Expenses
TransitionalExpenses
800000 USD
CY2014Q1 bios Transitional Expenses
TransitionalExpenses
700000 USD
CY2013Q4 bios Vehicles Gross
VehiclesGross
2056000 USD
CY2014Q1 bios Vehicles Gross
VehiclesGross
2132000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68424797 shares
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
BioScrip, Inc.

Files In Submission

Name View Source Status
0001014739-14-000006-index-headers.html Edgar Link pending
0001014739-14-000006-index.html Edgar Link pending
0001014739-14-000006.txt Edgar Link pending
0001014739-14-000006-xbrl.zip Edgar Link pending
bios-20140331.xml Edgar Link completed
bios-20140331.xsd Edgar Link pending
bios-20140331x10q.htm Edgar Link pending
bios-20140331_cal.xml Edgar Link unprocessable
bios-20140331_def.xml Edgar Link unprocessable
bios-20140331_lab.xml Edgar Link unprocessable
bios-20140331_pre.xml Edgar Link unprocessable
bios-ex311x20140331.htm Edgar Link pending
bios-ex312x20140331.htm Edgar Link pending
bios-ex321x20140331.htm Edgar Link pending
bios-ex322x20140331.htm Edgar Link pending
bioscriplogoa01a01a01.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending